Hiroshi Wakui

3.2k citations
42 papers · 816 indexed · h-index 15
Topics
Lung Cancer Treatments and Mutations (15 papers)Colorectal Cancer Treatments and Studies (8 papers)Cancer Immunotherapy and Biomarkers (7 papers)

In The Last Decade

Hiroshi Wakui

40 papers receiving 807 citations

Peers

Hiroshi Wakui
Comparison fields: 5 of 86
  • Oncology 412
  • Pulmonary and Respiratory Medicine 345
  • Molecular Biology 233
  • Immunology 103
  • Epidemiology 100
Replace Jiacheng Yin with:
Jiacheng Yin China
Chi‐Young Jeong South Korea
Raimondo Di Liello Italy
Yuichiro Miki Japan
Deepak Hariharan United Kingdom
William Tzu‐Liang Chen Taiwan
Yongfeng Ding China
Rosa Falcone Italy
Yasunori Shikada Japan
Meral Günaldı Türkiye
Hiroshi Wakui relative to Jiacheng Yin China Jiacheng Yin's profile →
Citations per field
00.5×20×40×66×
Jiacheng Yin · 1×
Citations per year

Countries citing papers authored by Hiroshi Wakui

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Wakui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Wakui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Wakui more than expected).

Fields of papers citing papers by Hiroshi Wakui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Wakui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Wakui. The network helps show where Hiroshi Wakui may publish in the future.

Co-authorship network of co-authors of Hiroshi Wakui

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Wakui. A scholar is included among the top collaborators of Hiroshi Wakui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Wakui. Hiroshi Wakui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 9
5 39
6 9
7 27
8 35
9 0
10 72
11 47
12 13
13 15
14 1
15 2
16 39
17 1
18 2
19 8
20 3

About Hiroshi Wakui

Hiroshi Wakui is a scholar working on Microbiology, Oncology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 816 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Oncology (412 citations), Pulmonary and Respiratory Medicine (345 citations) and Cancer Research (74 citations). Hiroshi Wakui has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hiroshi Nokihara, Noboru Yamamoto, Tomohide Tamura, Yasuhide Yamada, Hirofumi Utsumi, Yusuke Okuma, Shinji Nakamichi, Kazuyoshi Kuwano, Jun Araya and Yukio Hosomi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026